Vol 3 (October 31, 2022): Translational Breast Cancer Research

Case Report 
Presentation of metastatic breast cancer as a large bowel obstruction in an elderly female with resultant diverting ileostomy: case report
Samantha Greenseid, Kelsey Staudinger, Rosemary Morgan, Kenneth Blake
Translational Breast Cancer Research  
2022;
3:
38  
(31 October 2022) 
PDF Full Text (857) Reporting Checklist COI Form Open Access Get Permission
Original Article: Case Series 
Risk-reducing surgery in PALB2 mutations carriers with breast cancer: a case series and literature review
Monika K. Masanam, Clark W. Pitcher, Olutayo Sogunro, Leah K. Starks, Allison B. Murray, Marc E. Boisvert
Translational Breast Cancer Research  
2022;
3:
37  
(31 October 2022) 
PDF Full Text (4771) Reporting Checklist COI Form Open Access Get Permission
Editorial 
CSCO breast cancer management guidelines 2022: Australian perspective
Chen Han Yong, Anurag Gupta, Rohit Joshi
Translational Breast Cancer Research  
2022;
3:
36  
(31 October 2022) 
PDF Full Text (1303) COI Form Open Access Get Permission
Editorial 
An engineering feat of small proportions
Gerald M. Higa
Translational Breast Cancer Research  
2022;
3:
35  
(31 October 2022) 
PDF Full Text (459) COI Form Open Access Get Permission
Editorial 
Differences between Japan and China in perioperative pharmacotherapy of early-stage breast cancer in breast cancer guidelines (2022 edition)
Takashi Yamanaka, Toshinari Yamashita
Translational Breast Cancer Research  
2022;
3:
34  
(31 October 2022) 
PDF Full Text (933) COI Form Open Access Get Permission
Review Article 
Strategies for the treatment of HER2+ advanced breast cancer based on clinical practice in Chinese patients: a roundtable discussion
Quchang Ouyang, Min Yan, Xiaojia Wang, Qingyuan Zhang
Translational Breast Cancer Research  
2022;
3:
33  
(31 October 2022) 
PDF Full Text (1803) COI Form Open Access Get Permission
Review Article 
A round table discussion: clinical landscape of trastuzumab deruxtecan in breast cancer: a retrospective and prospective view
Xu Liang, Ying Yan, Guohong Song
Translational Breast Cancer Research  
2022;
3:
32  
(31 October 2022) 
PDF Full Text (1563) COI Form Open Access Get Permission
Original Article 
Efficacy and safety of margetuximab plus chemotherapy vs. trastuzumab plus chemotherapy in Chinese patients with pretreated HER2-positive advanced metastatic breast cancer: results from a randomized, open-label, multicenter, phase II bridging study
Qingyuan Zhang, Quchang Ouyang, Wei Li, Joanne Chiu, Min Yan, Yen-Shen Lu, Sanyuan Sun, Huiping Li, Yingying Du, Xujuan Wang, Tao Sun, Yongmei Yin, Haibo Wang, Feng Ye, Kunwei Shen, Jingfen Wang, Yueyin Pan, Shusen Wang, Jin Yang, Xiaohong Wu, Ming-Shen Dai, Jing Cheng, Yuee Teng, Fang Su, Xinhong Wu, Jingdong He, Peifen Fu, Lulu Yang, Yuan Xin, Xiaojia Wang, Zefei Jiang
Translational Breast Cancer Research  
2022;
3:
31  
(31 October 2022) 
PDF Full Text (1262) Reporting Checklist Data Sharing Statement COI Form Open Access Get Permission
Consensus 
Expert consensus on the clinical diagnosis and targeted therapy of HER2 breast cancer (2023 edition)
Jianbin Li, Xiaojia Wang, Shusen Wang, Shu Wang, Tao Wang, Yueping Liu, Cuizhi Geng, Feng Jin, Yongmei Yin, Qingyuan Zhang, Erwei Song, Jiong Wu, Zefei Jiang; Chinese Society of Clinical Oncology Breast cancer committee; Chinese Anti-Cancer Association; Committee of Breast Cancer Society
Translational Breast Cancer Research  
2022;
3:
30  
(31 October 2022) 
PDF Full Text (3802) COI Form Open Access Get Permission